Power-output values for the two beverages were referenced to values obtained for the carbohydrate (CHO) beverage, which was defined as baseline performance. Values on the Y-axis CH5183284 datasheet thus depicts the difference in performance between PROCHO and CHO ingestion and NpPROCHO and CHO ingestion, respectively, and is denoted as percentage. Figure 4 The effect of ingesting A) protein + carbohydrate (PROCHO) or B) Nutripeptin™ + protein + carbohydrate (NpPROCHO) on performance in a 5-min mean-power test following

120 min submaximal cycling at 50% of W max in the six lesser performing cyclists (lesser perf) compared to the six superior performing cyclists (superior perf). Power-output values for the two beverages were referenced to values obtained Selleck BMS 907351 for the carbohydrate (CHO) beverage, which was defined as baseline performance. Values on the Y-axis thus depicts the difference in performance between PROCHO and CHO ingestion and NpPROCHO and CHO ingestion, respectively, and is denoted as percentage. * = P < 0.05. N = 12. Discussion This is the first study to compare the effects

of ingesting supplements of protein and hydrolyzed protein on physical endurance performance. The results show that, with the current protocol, there was no mean effect on 5-min mean-power performance of ingesting the marine hydrolyzed protein-supplement Nutripeptin™ (Np) together with protein and carbohydrate during the preceding 120 min of submaximal cycling. Importantly, however, ingestion of the NpPROCHO-beverage resulted in an interesting correlation between performance in the 5-min mean-power test and athletic performance level

measured as a performance factor calculated from Wmax, VO2max and familiarization test 5-min mean-power performance. Although there are unavoidable uncertainties associated with analyzing data from a limited number of biological replicates, the confidence interval Nintedanib (BIBF 1120) analysis suggested a high level of credibility. The data thus indicates that for cyclists with a lower performance level, herein those showing VO2max values in the lower part of the participant cohort (decreasing towards 60 ml·kg-1·min-1), the Np-supplement may have had an ergogenic effect on 5-min mean-power performance compared to CHO alone. Indeed, when the cyclists were divided into two equally sized groups based on athletic performance level, NpPROCHO MAPK inhibitor improved 5-min mean-power output-performance relative to CHO in the lesser performing athletes but not in the superior performing athletes. The ergogenic effect in the lesser performing cyclists was associated with a large effect size.